Filing Details

Accession Number:
0001144204-11-031216
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-19 18:16:07
Reporting Period:
2011-05-17
Filing Date:
2011-05-19
Accepted Time:
2011-05-19 18:16:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1031735 L Derace Schaffer C/O Pharmathene, Inc.,
One Park Place, Suite 450
Annapolis MD 21401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-17 75,000 $3.71 1,210,208 No 4 S Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-18 50,000 $3.68 1,160,208 No 4 S Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-19 142,497 $3.68 1,017,711 No 4 S Indirect IRA account
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Indirect IRA account
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.67 to $3.77, inclusive. The reporting person undertakes to provide to PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.72, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.75, inclusive.